Accordingly, using genetically engineered mouse models (GEMMs), we observed that the BC Mir142−/−BCR-ABL mouse presented with significant T lymphopenia compared with the CP Mir142+/+BCR-ABL mouse (Supplementary Fig. 1c, d). Here, ABL1 is linked to breast cancer.